BENJAMIN WILLIAMSON: Open Payments
NPI 1467730093 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 47 payments from 11 companies in 2025. Trend: 2023 $211 · 2024 $458 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $160 |
| Alkermes, Inc. | 6 | $137 |
| Supernus Pharmaceuticals, Inc. | 5 | $114 |
| Janssen Pharmaceuticals, Inc | 4 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
| Bausch Health US, LLC | 3 | $64 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Lundbeck LLC | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, REXULTI, ARISTADA, HETLIOZ, APLENZIN, Qelbree.
Industry payments across CA — which companies pay providers there.
